Addex Therapeutics Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CHF 992,595 compared to CHF 860,793 a year ago. Operating loss was CHF 4.506 million compared to CHF 2.973 million a year ago. Net loss was CHF 4.690 million compared to CHF 3.114 million a year ago. Basic loss per share from continuing operations was CHF 0.14 compared to CHF 0.12 a year ago. For the half year, sales was CHF 1.836 million compared to CHF 1.764 million a year ago. Operating loss was CHF 7.654 million compared to CHF 7.246 million a year ago. Net loss was CHF 7.329 million compared to CHF 7.420 million a year ago. Basic loss per share from continuing operations was CHF 0.22 compared to CHF 0.28 a year ago.